Safety and immunogenicity of a booster dose of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in previously vaccinated healthy adults; a randomized controlled multicentre trial.

(Visited 4 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *